Alebund
PrivateLast Round
Series C
Jan 7, 2025
Total Funding Raised
$305.95M
Momentum Score
25 /100
Company Overview
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of innovative therapies for kidney diseases and related chronic conditions, focusing on research, regulatory approval, and commercialization of renal medicines with a diverse pipeline targeting various renal disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alebund Comps
Public and private peers based on sector, stage, and business model.
Alebund Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 7, 2025 | ||||
| VC Round | Apr 12, 2023 | ||||
| Debt | Apr 12, 2023 | ||||
| Series B Extension | Sep 13, 2021 | ||||
| Series B | May 9, 2021 |
Alebund Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series B Extension |
| YuanBio Venture Capital | Series B Extension |
| Morningside Ventures | Series B Extension |
| 3H Health Investment | Series B Extension |
| Xicheng Jinrui Investment Fund Management | Series C |
| Medfine Capital | Series B |
| Huagai Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 22, 2026
Will develop, manufacture, and commercialize kidney disease drug candidate AP306.
- Mar 22, 2026
Granted exclusive rights to develop kidney disease drug candidate outside Greater China.
Alebund Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alebund's valuation, stock price, and market status.
